ADKINS SEALE CAPITAL MANAGEMENT LLC

Position in PGEN — Precigen, Inc.

CIK 2147212 SHREVEPORT, LA

Position in PGEN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$71,250

+$22,875 QoQ

Shares Held

12,500

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#162

of 208 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ADKINS SEALE CAPITAL MANAGEMENT LLC holds $116,499 across 5 Biotechnology names. PGEN ranks #1 (61.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PGEN	Precigen, Inc. This page	12,500	$71,250
2	CGEN	Compugen Ltd	12,500	$26,750
3	CRSP	CRISPR Therapeutics AG	200	$10,908
4	ACAD	Acadia Pharmaceuticals Inc	300	$7,590
5	OGEN	Oragenics Inc	3	$1

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$71,250	12,500	0.0%	Shares	Sole	2026-08-05
2026-03-31	$48,375	12,500	0.0%	Shares	Sole	2026-08-05
2025-12-31	$52,250	12,500	—	Shares	Sole	2026-08-05
No filing history on record for this holder in this stock.